bioAffinity reports 95% quarterly jump in lung cancer test sales
Go back to bioAffinity reports 95% quarterly jump in lung cancer test sales| (NASDAQ: BIAF) | Delayed: 0.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.40 | 52 Week High | $ | |||
| Open | $0.38 | 52 Week Low | $ | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.37 | EPS | $ | |||
| Volume | 688,018 | |||||
| (NASDAQ: BIAFW) | Delayed: 0.12 +0.02 (20.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.10 | 52 Week High | $ | |||
| Open | $0.09 | 52 Week Low | $ | |||
| Day High | $0.14 | P/E | N/A | |||
| Day Low | $0.08 | EPS | $ | |||
| Volume | 4,050 | |||||

